Lifecore Biomedical, Inc. · LSX:899376

Lifecore Biomedical, Inc. financial statements

Lifecore Biomedical, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue129.5M128.9M128.3M103.3M111.3M100.9M160.1M557.6M524.2M469.8M
Cost of revenue88.9M88.6M86.4M75.3M72.2M61.9M120.7M476.6M445.9M390.6M
Gross profit40.6M40.3M41.9M28.0M39.1M38.9M39.4M81.0M78.3M79.2M
Research and development8.50M8.26M8.57M8.74M7.84M6.68M7.58M11.5M12.8M9.47M
Selling, general and administrative44.0M40.5M39.0M34.7M27.7M40.7M62.1M52.0M52.5M
Operating income-1.26M-17.2M-8.84M-21.8M-11.8M-8.82M-25.9M5.47M13.6M14.7M
Depreciation and amortization9.50M8.03M7.95M13.2M18.1M19.9M18.8M15.2M12.4M10.7M
EBITDA8.24M-9.22M-890.0K-8.62M6.27M11.0M-7.04M20.7M26.0M25.3M
Interest expense2.21M22.2M18.1M17.6M15.6M8.93M4.65M5.23M1.95M1.83M
Income before tax-30.2M-38.7M9.51M-63.9M-20.7M-29.8M-30.6M3.64M16.4M14.2M
Income tax577.7K43.0K183.0K308.0K-5.21M-6.35M-8.77M1.52M-9.36M4.04M
Net income-30.8M-38.7M12.0M-99.6M-116.7M-32.3M-38.2M411.0K24.8M10.6M
Earnings per share, basic-0.82-1.270.39-3.32-3.97-1.10-1.310.010.900.39
Earnings per share, diluted-1.270.33-3.32-3.97-1.10-1.310.010.890.38

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents17.5M8.27M8.46M19.1M991.0K763.0K360.0K1.08M2.90M6.00M
Receivables33.8M43.7M31.2M29.0M38.3M31.6M76.2M69.6M53.9M45.9M
Inventory29.1M32.3M40.0M40.8M36.0M33.9M66.3M54.1M31.8M23.6M
Current assets82.3M85.7M81.0M93.9M116.7M145.3M157.1M133.0M97.1M81.3M
Property, plant and equipment129.0M149.2M134.4M118.7M107.1M192.3M200.0M159.6M133.2M
Goodwill13.9M13.9M13.9M13.9M13.9M13.9M33.9M76.7M54.5M54.5M
Total assets232.2M239.3M254.0M253.5M274.7M501.9M293.5M519.1M404.7M358.6M
Accounts payable5.84M8.22M16.3M22.1M13.0M11.6M51.6M54.0M34.7M24.5M
Current liabilities23.6M30.2M38.9M39.3M176.6M101.9M164.4M137.1M88.4M51.5M
Long-term debt135.6M127.0M100.8M84.3M0164.9M101.4M87.2M37.4M42.3M
Total debt142.6M130.4M124.7M84.8M98.2M164.9M112.9M97.0M42.3M47.2M
Total liabilities246.4M191.9M200.1M218.5M186.9M299.9M310.3M248.9M152.1M130.5M
Shareholders' equity-14.2M1.34M11.3M-4.23M87.8M201.9M229.8M270.1M252.6M226.6M
Shares outstanding37.4M37.0M30.6M30.3M29.5M29.3M29.2M29.1M27.7M27.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations12.6M-206.0K257.0K-17.4M-22.6M16.5M-17.0M16.0M19.8M29.8M
Capital spending-6.34M-13.4M-18.4M-29.9M-26.2M-19.3M-12.2M-44.7M-33.6M-23.0M
Free cash flow6.23M-13.6M-18.1M-52.5M-48.8M-2.79M-29.3M-28.7M-13.8M6.83M
Cash from investing-1.63M-6.42M-18.4M-4.81M80.0M-12.3M-23.9M-96.8M-35.6M-25.4M
Cash from financing-1.11M6.42M7.51M39.7M-57.0M-3.42M40.0M79.0M13.3M-8.80M
Dividends paid-3.08M-274.0K-212.0K-700.0K
Share buybacks-1.94M-152.0K-789.0K-405.0K-212.0K-700.0K-1.48M-434.0K
Change in cash-197.0K-197.0K-10.6M17.4M348.0K742.0K-912.0K-1.75M-2.52M-4.38M